Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial
Stelmaszewski, Erica V, Parente, Daniella B, Farina, Alberto, Stein, Anna, Gutierrez, Anthony, Raquelo-Menegassio, Antonio F, Manterola, Carla, de Sousa, Carolina F, Victor, Carolina, Maki, Dina, Morón, Elias M, de Abrantes, Fabiano F, Iqbal, Fatima, Camacho-Vilchez, Jazmin, Jimenez-Pavón, Joanna, Polania, Juan P, Thompson, Lorenzo, Bonanato, Lygia, Diebold, Matthias, Da Silva, Maria V C P, Nashwan, Mariam W J, Galvani, Marianna A G, Idris, Osama E A, Danos, Pierina, Ortiz-Lopez, Rocio, Mahmoud, Rofida A A, Gresse, Sergio, Loss, Karla L
Published in Cardiology in the young (01.03.2020)
Published in Cardiology in the young (01.03.2020)
Get full text
Journal Article